Cargando…

Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience

Permanent prostate brachytherapy is frequently performed worldwide, and many studies have demonstrated its favorable outcomes. Implant seeds used in this procedure contain a precise amount of radionuclide and are completely sealed. Because these seeds are not manufactured in Japan, they are expensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Kana, Okihara, Koji, Iwata, Tsuyoshi, Aibe, Norihiro, Kodani, Naohiro, Tsubokura, Takuji, Kamoi, Kazumi, Miki, Tsuneharu, Yamazaki, Hideya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650751/ https://www.ncbi.nlm.nih.gov/pubmed/23292147 http://dx.doi.org/10.1093/jrr/rrs126

Ejemplares similares

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
por: Yamazaki, Hideya, et al.
Publicado: (2011)

A Case of Thyroid Papillary Carcinoma: Remarkable Decrease in Multiple Lung Metastases within 40 Years after a Single Administration of Radioiodine without Thyroidectomy and with Later Anaplastic Transformation
por: Okuyama, Chio, et al.
Publicado: (2017)

Effect of constipation on dosimetry after permanent seed brachytherapy for prostate cancer
por: Otón, L. Fernando, et al.
Publicado: (2015)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Complete response of sunitinib therapy for renal cell cancer recurrence in the native kidney after renal transplantation: a case report
por: Hongo, Fumiya, et al.
Publicado: (2014)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2017)

Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy
por: Tiberi, David, et al.
Publicado: (2014)

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Author Correction: Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses
por: Hongo, Fumiya, et al.
Publicado: (2017)

Importance of Continuous Sequential Chemotherapy and Multimodal Treatment for Advanced Testicular Cancer: A High-Volume Japanese Center Experience
por: Nakamura, Terukazu, et al.
Publicado: (2015)

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS
por: Ishiyama, Hiromichi, et al.
Publicado: (2016)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
por: Matsugasumi, Toru, et al.
Publicado: (2021)

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Small bowel perforation caused by applicator implantation in high-dose-rate interstitial brachytherapy for recurrent pelvic tumor: a case report
por: Masui, Koji, et al.
Publicado: (2020)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy
por: Ishiyama, Hiromichi, et al.
Publicado: (2016)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Influence of zonal dosimetry on prostate brachytherapy outcomes
por: Hong, Cheng William, et al.
Publicado: (2015)

A seed specific dose kernel method for low‐energy brachytherapy dosimetry
por: DeMarco, John J., et al.
Publicado: (2003)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Optically Stimulated Luminescent Dosimetry for High Dose Rate Brachytherapy
por: Tien, Christopher Jason, et al.
Publicado: (2012)

Evaluation and implementation of triple‐channel radiochromic film dosimetry in brachytherapy
por: Palmer, Antony L, et al.
Publicado: (2014)

Interface dosimetry for electronic brachytherapy intracavitary breast balloon applicators
por: Segala, James J., et al.
Publicado: (2011)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
por: Ota, Yoshiaki, et al.
Publicado: (2020)

Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bfo94nomrqvraa6fn30g97i20d